TOKYO: SoftBank Group Corp sold roughly US$14bil (RM59.34bil) worth of listed stocks last quarter, nearly triple the amount in the previous period, as the company increases pace of investment in technology startups. SoftBank’s founder Masayoshi Son, (pic) known for his reluctance to cash in on investments, is signalling a new appetite for exits to finance the accelerating pace of deal-making at his Vision Fund investment arm. Son also doubled the pot for Vision Fund 2, where the company is a sole investor, to US$40bil (RM169.52bil) since the end of March. Bloomberg estimated the amount of money it got through multiplying the number of shares sold by the average price of each stock during the quarter. Separately, the Vision Fund disposed of almost 5.6 million shares of Guardant Health Inc, a California-based biotech company, and 23.4 million shares of Chinese online property platform KE Holdings Inc.
